Lowe's CompaniesvsMEDIROM Healthcare Technologies

LOW and MRM stock compared: price, dividend, valuation and results, from SEC filings.

Lowe's Companies (LOW) has a market value of $124B and MEDIROM Healthcare Technologies (MRM) $1.8M. Over the last year, with dividends, LOW moved -1.2% and MRM -88.9%. Dividend yield: LOW 2.22%, MRM none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    LOW$124B

    MRM$1.8M

    LOW is 68,054 times MRM

  • Revenue, 12 months

    LOW$90.4B

    MRM$50M

    LOW is 1,827 times MRM

  • Net income, 12 months

    LOW$6.6B

    MRM-$23M

  • Operating margin

    LOW11.4%

    MRM-43.7%

    55.1 points apart

  • ROIC

    LOW27.6%

    MRM–

  • P/E

    LOW18.7

    MRM–

  • Dividend yield

    LOW2.2%

    MRM0.0%

    2.2 points apart

  • 5-year return

    LOW-2.2%

    MRM-97.0%

    94.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

LOW-2.2%

MRM-97.0%

05010020222023202420252026
Returns by period
PeriodLOWWith dividendsMRMWith dividends
1 year since November 19, 2025-1.2%Price -3.3%-88.9%Price -88.9%
3 years since November 20, 2023+14.8%+4.7% a yearPrice +8.0%-95.3%-63.9% a yearPrice -95.3%
5 years since November 19, 2021-2.2%-0.5% a yearPrice -11.5%-97.0%-50.4% a yearPrice -97.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

LOWLowe's CompaniesMRMMEDIROM Healthcare Technologies

Valuation

LOWMRM
Valuation
Price$220.84$0.23
Market value$124B$1.8M
Enterprise value (EV)$158B–
P/E18.7–
P/E, 5-year median21.221.8
P/B––
EV/EBIT15.3–
Free cash flow yield5.7%–

Results and growth

LOWMRM
Results and growth
Revenue, 12 months$90.4B$50M
Net income, 12 months$6.6B-$23M
Free cash flow, 12 months$7.0B-$7.4M
Earnings per share, 12 months$11.83-$2.93
Revenue growth, year on year3.1%-6.5%
Revenue growth a year, past-0.8%over 5 years+18.4%over 5 years
EPS growth a year, past+8.9%over 5 years–

Margins and returns on capital

LOWMRM
Margins and returns on capital
Gross margin33.1%–
Operating margin11.4%-43.7%
Net margin7.3%-46.8%
ROIC27.6%–
ROE––

Balance sheet

LOWMRM
Balance sheet
Cash$3.4B$625.9K
Total debt$42.0B–
Net debt / EBITDA2.7–
Interest cover––

Dividends and buybacks

LOWMRM
Dividends and buybacks
Dividend yield2.2%–
Dividend per share, 12 months$4.90–
Dividend growth a year, past+15.6%over 5 years–
Buyback yield0.2%–
Shareholder yield2.4%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: LOW or MRM

Didn't find what you were looking for?

Ask us
Which is bigger, Lowe's Companies or MEDIROM Healthcare Technologies?

By market value, Lowe's Companies ($124B) is about 68,053.9 times MEDIROM Healthcare Technologies ($1.8M), at today's prices.

How did LOW and MRM stock do over the last 5 years?

Since November 19, 2021, LOW's price moved -11.5% and MRM's -97.0%. With dividends: LOW -2.2% (-0.5% a year), MRM -97.0% (-50.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, LOW or MRM?

The dividend yield at today's price is 2.22% for Lowe's Companies and none for MEDIROM Healthcare Technologies. Over the last twelve months they paid $4.90 and – per share.

Which has the higher profit margins, Lowe's Companies or MEDIROM Healthcare Technologies?

Over the last twelve months, the net margin was 7.3% for Lowe's Companies and -46.8% for MEDIROM Healthcare Technologies, and the operating margin 11.4% and -43.7%. Revenue was $90.4B and $50M.

Which is the better investment, Lowe's Companies or MEDIROM Healthcare Technologies?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.